Back to search
Pharmacogenomic Drug Interaction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacogenomic Drug Interaction trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Pharmacogenomic Drug Interaction trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study looks at how a medicine called trihexyphenidyl works in children with dystonic cerebral palsy. The study aims to understand how trihexyphenidyl is br…
The objectives of this study are to (1) test the feasibility of the clinical implementation of preemptive pharmacogenetic (PGx) testing in the emergency departm…
It is known that individuals respond differently to the same medicine with some people benefitting, some experiencing no effect and others suffering side-effect…
A five-year prospective observational cohort study. The study is focused on observing the relation between static germline variants and therapeutic response in…
The goal of this project is to determine whether pharmacogenomic testing (using participants' DNA) can help optimize medication prescribing and reduce side effe…
The purpose of this study is to determine whether the implementation of pre-emptive pharmacogenomic (PGx) testing of a panel of clinically relevant PGx markers,…
The goal of this prospective, randomized clinical trial is to learn whether pharmacogenomic (PGx)-guided comprehensive medication management delivered by pharma…
The goal of this research study is to reduce adverse effects of anti-cancer medications known as kinase inhibitors, while preserving their therapeutic benefits.…